In the tumor immune microenvironment of RCC, IL-6 induces the expression of SOCS3 (suppressor of cytokine signaling-3), a negative regulator of cytokine signaling that promotes tumor cell invasion and metastasis. Here, SOCS3 is linked to neoplasm.